FDA places hold on trial of cell therapy for lung cancer after patient death

1 year ago 44

The FDA placed a clinical hold on a trial designed to evaluate a novel cell therapy for non-small cell lung cancer after one study participant died.LN-145 (Iovance Biotherapeutics) is an autologous tumor-infiltrating lymphocyte therapy.

1. Homepage
2. Lung Cancer
3. FDA places hold on trial of cell therapy for lung cancer after patient death